Market News & Analysis

Top Story

EU indices mostly closed for Labor Day | TA focus on Ryanair

Yesterday, European stocks turned to the downside, with the Stoxx Europe 600 Index falling 2.0%. Germany's DAX 30 lost 2.2%, France's CAC 40 slipped 2.1%, and the U.K.'s FTSE 100 slumped 3.5%.

80% of STOXX 600 constituents traded lower or unchanged yesterday.
86% of the shares trade above their 20D MA vs 95% Wednesday (above the 20D moving average).
23% of the shares trade above their 200D MA vs 26% Wednesday (above the 20D moving average).

The Euro Stoxx 50 Volatility index added 3.19pts to 33.91, a new 52w high.

3mths relative high: none
3mths relative low: none

Europe Best 3 sectors
personal & household goods, real estate, utilities

Europe worst 3 sectors
banks, basic resources, insurance

The 10yr Bund yield fell 3bps to -0.5% (below its 20D MA). The 2yr-10yr yield spread rose 4bps to -17bps (above its 20D MA).

UK 09:30: Mar Net Lending to Individuals MoM, exp.: £5.2B
UK 09:30: Mar Mortgage Approvals, exp.: 73.55K
UK 09:30: Mar Mortgage Lending, exp.: £4B
UK 09:30: Mar BoE Consumer Credit, exp.: £0.9B
UK 09:30: Apr Markit/CIPS Manufacturing PMI final, exp.: 47.8

In Asian trading hours, EUR/USD firmed at 1.0945 while GBP/USD eased to 1.2563. USD/JPY held above the 107.00 level.

Spot gold rebounded to $1,690 an ounce.

U.K. house prices grew 0.7% on month in April (-0.3% expected), according to the Nationwide Building Society.

Ryanair, an airline group, posted a COVID-19 update: "The Ryanair Airlines will shortly notify their trade unions about its restructuring and job loss program, (...) and may result in the loss of up to 3,000 mainly pilot and cabin crew jobs, (...) The Group expects to report a net loss of over E100m in Q1, with further losses in Q2 (peak summer) due to the substantial decline in traffic arising from Covid-19 fleet groundings. Ryanair expects that its return to scheduled services will be rendered more difficult by competing with flag carrier airlines, who will be financing below cost selling with the benefit of over E30 billion in unlawful State Aid, in breach of both EU State Aid and competition rules."

Source: GAIN Capital, TradingView

Barratt Developments, a house-builder, released a COVID-19 update: "Work on our construction sites will recommence from 11 May, initially to implement the changes required under our new working practices and protocols. We will then start a phased return to construction, with 180 sites - around 50% of the total - in the first phase. (...) Initially our construction activities will prioritize sold plots at advanced stages of construction, and we therefore expect a limited number of additional completions this financial year. As at 26 April 2020, the Group has completed 11,776 homes (2019: 11,723 homes) (including JVs). Our total forward sales are 12,271 homes at a value of £2,852.9m (including JVs)."

Lloyds Banking Group, a major U.K. banking group, announced that Chief Operating Officer Juan Colombas has agreed to delay his retirement, and will remain in the post until September 18, 2020."

Royal Dutch Shell, an oil giant, was downgraded to "hold" from "buy" at HSBC.

Next, a retail group, was upgraded to "buy" from "hold" at HSBC.

Allianz, a financial services group, said it expects 1Q net income of 1.4 billion euros, down from 2.0 billion euros in the prior-year period, and operating profit is estimated to drop to 2.3 billion euros from 3.0 billion euros. In addition, the company announced the withdrawal of 2020 operating profit target of 11.5 - 12.5 billion euros, citing the current COVID-19 pandemic.

Wirecard, a digital financial commerce platform operator, was downgraded to "equalweight" from "overweight" at Morgan Stanley.

Societe Generale, a banking group, was downgraded to "neutral" from "buy" at Citigroup.

Ageas, an insurance group, was upgraded to "overweight" from "neutral" at JPMorgan.

Lonza Group, a clinical stage biotechnology company, announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional Moderna products in the future. The company said: "Our common goal is to potentially enable manufacturing of up to 1 billion doses of mRNA-1273."


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.